BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parker SL, Kane JK, Parker MS, Berglund MM, Lundell IA, Li MD. Cloned neuropeptide Y (NPY) Y 1 and pancreatic polypeptide Y 4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y 2 receptor: Internalization of Y1, Y2 and Y4 receptors. European Journal of Biochemistry 2001;268:877-86. [DOI: 10.1046/j.1432-1327.2001.01966.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Walther C, Nagel S, Gimenez LE, Mörl K, Gurevich VV, Beck-Sickinger AG. Ligand-induced internalization and recycling of the human neuropeptide Y2 receptor is regulated by its carboxyl-terminal tail. J Biol Chem 2010;285:41578-90. [PMID: 20959467 DOI: 10.1074/jbc.M110.162156] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
2 Parker MS, Lundell I, Parker SL. Pancreatic polypeptide receptors: affinity, sodium sensitivity and stability of agonist binding 1 1Abbreviations: NPY, neuropeptide Y; hNPY, human NPY; PYY, peptide YY; pPYY, porcine PYY; LP-PYY, (Leu31,Pro34) human peptide YY; hPP, rPP, human and rat pancreatic polypeptide, respectively; hPYY [3–36], human peptide YY [3–36]; EIPA, 5-(N-ethyl, N-isopropyl)amiloride; DMA, 5-(N, N-dimethyl)amiloride; HEXA, 5-(N, N-hexamethylene)amiloride; MIA, 5-N(methyl, N-isobutyl)amiloride; CHO, Chinese hamster ovary; PEG, polyethylene glycol. Peptides 2002;23:291-303. [DOI: 10.1016/s0196-9781(01)00610-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
3 D'Angelo I, Oh SJ, Chun MH, Brecha NC. Localization of neuropeptide Y1 receptor immunoreactivity in the rat retina and the synaptic connectivity of Y1 immunoreactive cells. J Comp Neurol 2002;454:373-82. [PMID: 12455004 DOI: 10.1002/cne.10423] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
4 Parker SL, Parker MS, Lundell I, Balasubramaniam A, Buschauer A, Kane JK, Yalcin A, Berglund MM. Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells shows strong preference for NPY, endosome-linked entry and fast receptor recycling. Regul Pept 2002;107:49-62. [PMID: 12137966 DOI: 10.1016/s0167-0115(02)00094-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
5 Parker MS, Sah R, Balasubramaniam A, Parker SL. Lithium inhibits internalization and endosomal processing of both neuropeptide Y (NPY) Y1 and transferrin receptors. Neuroscience Letters 2005;374:43-6. [DOI: 10.1016/j.neulet.2004.10.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Cattaneo S, Verlengia G, Marino P, Simonato M, Bettegazzi B. NPY and Gene Therapy for Epilepsy: How, When,... and Y. Front Mol Neurosci 2020;13:608001. [PMID: 33551745 DOI: 10.3389/fnmol.2020.608001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Parker SL, Parker MS, Sah R, Balasubramaniam A, Sallee FR. Pertussis toxin induces parallel loss of neuropeptide Y Y1 receptor dimers and Gi alpha subunit function in CHO cells. Eur J Pharmacol 2008;579:13-25. [PMID: 17967449 DOI: 10.1016/j.ejphar.2007.10.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
8 Sah R, Balasubramaniam A, Parker MS, Sallee F, Parker SL. Neuropeptide Y as a partial agonist of the Y1 receptor. Eur J Pharmacol 2005;525:60-8. [PMID: 16293244 DOI: 10.1016/j.ejphar.2005.10.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
9 Nederpelt I, Bunnik J, Ijzerman AP, Heitman LH. Kinetic Profile of Neuropeptide–Receptor Interactions. Trends in Neurosciences 2016;39:830-9. [DOI: 10.1016/j.tins.2016.09.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
10 Dumont Y, Quirion R. An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization. In: Zukowska Z, Feuerstein GZ, editors. NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics. Basel: Birkhäuser-Verlag; 2006. pp. 7-33. [DOI: 10.1007/3-7643-7417-9_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Estes A, Mcallen K, Parker MS, Sah R, Sweatman T, Park EA, Balasubramaniam A, Sallee FR, Walker MW, Parker SL. Maintenance of Y receptor dimers in epithelial cells depends on interaction with G-protein heterotrimers. Amino Acids 2011;40:371-80. [DOI: 10.1007/s00726-010-0642-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
12 Berglund MM, Schober DA, Statnick MA, Mcdonald PH, Gehlert DR. The Use of Bioluminescence Resonance Energy Transfer 2 to Study Neuropeptide Y Receptor Agonist-Induced β-Arrestin 2 Interaction. J Pharmacol Exp Ther 2003;306:147-56. [DOI: 10.1124/jpet.103.051227] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 3.4] [Reference Citation Analysis]
13 Parker M, Sah R, Sheriff S, Balasubramaniam A, Parker S. Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonists. Regulatory Peptides 2005;132:91-101. [DOI: 10.1016/j.regpep.2005.09.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
14 Fatoba O, Kloster E, Reick C, Saft C, Gold R, Epplen JT, Arning L, Ellrichmann G. Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease. Experimental Neurology 2018;302:112-28. [DOI: 10.1016/j.expneurol.2018.01.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
15 Merten N, Beck-Sickinger AG. Molecular ligand-receptor interaction of the NPY/PP peptide family. EXS 2006;:35-62. [PMID: 16382996 DOI: 10.1007/3-7643-7417-9_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
16 Parker SL, Parker MS, Sah R, Sallee F. Angiogenesis and rhodopsin-like receptors: a role for N-terminal acidic residues? Biochem Biophys Res Commun 2005;335:983-92. [PMID: 16023616 DOI: 10.1016/j.bbrc.2005.06.158] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
17 Marion S, Oakley RH, Kim KM, Caron MG, Barak LS. A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors. J Biol Chem 2006;281:2932-8. [PMID: 16319069 DOI: 10.1074/jbc.M508074200] [Cited by in Crossref: 85] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
18 Pleil KE, Rinker JA, Lowery-Gionta EG, Mazzone CM, McCall NM, Kendra AM, Olson DP, Lowell BB, Grant KA, Thiele TE, Kash TL. NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking. Nat Neurosci 2015;18:545-52. [PMID: 25751534 DOI: 10.1038/nn.3972] [Cited by in Crossref: 123] [Cited by in F6Publishing: 113] [Article Influence: 17.6] [Reference Citation Analysis]
19 Parker SL, Parker MS, Buschauer A, Balasubramaniam A. Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides. European Journal of Pharmacology 2003;474:31-42. [DOI: 10.1016/s0014-2999(03)02039-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
20 Gehlert DR. Introduction to the reviews on neuropeptide Y. Neuropeptides 2004;38:135-40. [PMID: 15337366 DOI: 10.1016/j.npep.2004.07.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
21 Parker SL, Parker MS, Sah R, Balasubramaniam A, Sallee FR. Self-regulation of agonist activity at the Y receptors. Peptides 2007;28:203-13. [PMID: 17194507 DOI: 10.1016/j.peptides.2006.07.032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
22 Mäde V, Babilon S, Jolly N, Wanka L, Bellmann-sickert K, Diaz gimenez LE, Mörl K, Cox HM, Gurevich VV, Beck-sickinger AG. Peptide Modifications Differentially Alter G Protein-Coupled Receptor Internalization and Signaling Bias. Angew Chem 2014;126:10231-5. [DOI: 10.1002/ange.201403750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
23 Pop N, Igel P, Brennauer A, Cabrele C, Bernhardt G, Seifert R, Buschauer A. Functional reconstitution of human neuropeptide Y (NPY) Y 2 and Y 4 receptors in Sf9 insect cells. Journal of Receptors and Signal Transduction 2011;31:271-85. [DOI: 10.3109/10799893.2011.583253] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
24 Balasubramaniam A, Mullins DE, Lin S, Zhai W, Tao Z, Dhawan VC, Guzzi M, Knittel JJ, Slack K, Herzog H, Parker EM. Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity. J Med Chem 2006;49:2661-5. [PMID: 16610810 DOI: 10.1021/jm050907d] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
25 Doi N, Yamakawa N, Matsumoto H, Yamamoto Y, Nagano T, Matsumura N, Horisawa K, Yanagawa H. DNA display selection of peptide ligands for a full-length human G protein-coupled receptor on CHO-K1 cells. PLoS One 2012;7:e30084. [PMID: 22253889 DOI: 10.1371/journal.pone.0030084] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
26 Bech EM, Kaiser A, Bellmann-sickert K, Nielsen SS, Sørensen KK, Elster L, Hatzakis N, Pedersen SL, Beck-sickinger AG, Jensen KJ. Half-Life Extending Modifications of Peptide YY 3–36 Direct Receptor-Mediated Internalization. Mol Pharmaceutics 2019;16:3665-77. [DOI: 10.1021/acs.molpharmaceut.9b00554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
27 Klompus M, Ho W, Sharkey KA, McKay DM. Antisecretory effects of neuropeptide Y in the mouse colon are region-specific and are lost in DSS-induced colitis. Regul Pept. 2010;165:138-145. [PMID: 20561896 DOI: 10.1016/j.regpep.2010.05.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
28 Parker MS, Parker SL, Kane JK. Internalization of neuropeptide Y Y1 and Y5 and of pancreatic polypeptide Y4 receptors is inhibited by lithium in preference to sodium and potassium ions. Regulatory Peptides 2004;118:67-74. [DOI: 10.1016/j.regpep.2003.10.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
29 Gicquiaux H, Lecat S, Gaire M, Dieterlen A, Mély Y, Takeda K, Bucher B, Galzi J. Rapid Internalization and Recycling of the Human Neuropeptide Y Y1 Receptor. Journal of Biological Chemistry 2002;277:6645-55. [DOI: 10.1074/jbc.m107224200] [Cited by in Crossref: 87] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
30 Mörl K, Beck-Sickinger AG. Intracellular Trafficking of Neuropeptide Y Receptors. Prog Mol Biol Transl Sci 2015;132:73-96. [PMID: 26055055 DOI: 10.1016/bs.pmbts.2015.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
31 Parker SL, Parker MS, Kane JK, Berglund MM. A pool of Y2 neuropeptide Y receptors activated by modifiers of membrane sulfhydryl or cholesterol balance. Eur J Biochem 2002;269:2315-22. [PMID: 11985613 DOI: 10.1046/j.1432-1033.2002.02903.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
32 Böhme I, Mörl K, Bamming D, Meyer C, Beck-Sickinger AG. Tracking of human Y receptors in living cells--a fluorescence approach. Peptides 2007;28:226-34. [PMID: 17207557 DOI: 10.1016/j.peptides.2006.08.042] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
33 Holliday ND, Lam CW, Tough IR, Cox HM. Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization. Mol Pharmacol 2005;67:655-64. [PMID: 15576634 DOI: 10.1124/mol.104.006114] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
34 Lundell I, Rabe Bernhardt N, Johnsson A, Larhammar D. Internalization studies of chimeric neuropeptide Y receptors Y1 and Y2 suggest complex interactions between cytoplasmic domains. Regulatory Peptides 2011;168:50-8. [DOI: 10.1016/j.regpep.2011.03.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
35 Hurtado MD, Acosta A, Riveros PP, Baum BJ, Ukhanov K, Brown AR, Dotson CD, Herzog H, Zolotukhin S. Distribution of Y-receptors in murine lingual epithelia. PLoS One 2012;7:e46358. [PMID: 23050020 DOI: 10.1371/journal.pone.0046358] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
36 Sheriff S, F Qureshy A, T Chance W, Kasckow JW, Balasubramaniam A. Predominant role by CaM kinase in NPY Y(1) receptor signaling: involvement of CREB [corrected]. Peptides 2002;23:87-96. [PMID: 11814622 DOI: 10.1016/s0196-9781(01)00583-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
37 Chen G, Yang F, Wu T, Jiang J, Zhou W. The Stimulatory Effect of Cerebral Intraventricular Injection of cNPY on Precocial Feeding Behavior in Neonatal Chicks (Gallus domesticus). PLoS One 2016;11:e0153342. [PMID: 27055273 DOI: 10.1371/journal.pone.0153342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
38 Walther C, Mörl K, Beck-Sickinger AG. Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development. J Pept Sci 2011;17:233-46. [PMID: 21351324 DOI: 10.1002/psc.1357] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
39 Parker MS, Lundell I, Parker SL. Internalization of pancreatic polypeptide Y4 receptors: correlation of receptor intake and affinity. European Journal of Pharmacology 2002;452:279-87. [DOI: 10.1016/s0014-2999(02)02339-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Li J, Shen Z, Ma X, Ren W, Xiang L, Gong A, Xia T, Guo J, Wu A. Neuropeptide Y Y 1 Receptors Meditate Targeted Delivery of Anticancer Drug with Encapsulated Nanoparticles to Breast Cancer Cells with High Selectivity and Its Potential for Breast Cancer Therapy. ACS Appl Mater Interfaces 2015;7:5574-82. [DOI: 10.1021/acsami.5b00270] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
41 Eva C, Serra M, Mele P, Panzica G, Oberto A. Physiology and gene regulation of the brain NPY Y1 receptor. Frontiers in Neuroendocrinology 2006;27:308-39. [DOI: 10.1016/j.yfrne.2006.07.002] [Cited by in Crossref: 99] [Cited by in F6Publishing: 99] [Article Influence: 6.2] [Reference Citation Analysis]
42 Berglund MM, Hipskind PA, Gehlert DR. Function, distribution and molecular pharmacology of NPY-family receptors. In: Zukowska Z, Feuerstein GZ, editors. The NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis and Cancer. Basel: Birkhäuser-Verlag; 2005. pp. 29-62. [DOI: 10.1007/3-7643-7427-6_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Sørensen AT, Kanter-schlifke I, Carli M, Balducci C, Noe F, During MJ, Vezzani A, Kokaia M. NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus 2008;18:564-74. [DOI: 10.1002/hipo.20415] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
44 Mäde V, Babilon S, Jolly N, Wanka L, Bellmann-Sickert K, Diaz Gimenez LE, Mörl K, Cox HM, Gurevich VV, Beck-Sickinger AG. Peptide modifications differentially alter G protein-coupled receptor internalization and signaling bias. Angew Chem Int Ed Engl 2014;53:10067-71. [PMID: 25065900 DOI: 10.1002/anie.201403750] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
45 Pheng LH, Dumont Y, Fournier A, Chabot JG, Beaudet A, Quirion R. Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. Br J Pharmacol 2003;139:695-704. [PMID: 12812992 DOI: 10.1038/sj.bjp.0705306] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
46 Parker MS, Berglund MM, Lundell I, Parker SL. Blockade of pancreatic polypeptide-sensitive neuropeptide Y (NPY) receptors by agonist peptides is prevented by modulators of sodium transport. Implications for receptor signaling and regulation. Peptides 2001;22:887-98. [DOI: 10.1016/s0196-9781(01)00414-4] [Cited by in Crossref: 18] [Article Influence: 0.9] [Reference Citation Analysis]
47 Parker MS, Sah R, Balasubramaniam A, Park EA, Sallee FR, Parker SL. Dimers of G-protein coupled receptors as versatile storage and response units. Int J Mol Sci 2014;15:4856-77. [PMID: 24651459 DOI: 10.3390/ijms15034856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Bugarith K, Dinh TT, Li AJ, Speth RC, Ritter S. Basomedial hypothalamic injections of neuropeptide Y conjugated to saporin selectively disrupt hypothalamic controls of food intake. Endocrinology 2005;146:1179-91. [PMID: 15604214 DOI: 10.1210/en.2004-1166] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
49 Estes A, Wong Y, Parker M, Sallee F, Balasubramaniam A, Parker S. Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric. Regulatory Peptides 2008;150:88-94. [DOI: 10.1016/j.regpep.2008.06.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
50 Glass MJ, Chan J, Pickel VM. Ultrastructural localization of neuropeptide Y Y1 receptors in the rat medial nucleus tractus solitarius: Relationships with neuropeptide Y or catecholamine neurons. J Neurosci Res 2002;67:753-65. [DOI: 10.1002/jnr.10185] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
51 Kempf N, Didier P, Postupalenko V, Bucher B, Mély Y. Internalization mechanism of neuropeptide Y bound to its Y 1 receptor investigated by high resolution microscopy. Methods Appl Fluoresc 2015;3:025004. [DOI: 10.1088/2050-6120/3/2/025004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
52 Böhme I, Stichel J, Walther C, Mörl K, Beck-sickinger AG. Agonist induced receptor internalization of neuropeptide Y receptor subtypes depends on third intracellular loop and C-terminus. Cellular Signalling 2008;20:1740-9. [DOI: 10.1016/j.cellsig.2008.05.017] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
53 Kamiji MM, Inui A. Neuropeptide y receptor selective ligands in the treatment of obesity. Endocr Rev 2007;28:664-84. [PMID: 17785427 DOI: 10.1210/er.2007-0003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
54 Berglund MM, Hipskind PA, Gehlert DR. Recent Developments in Our Understanding of the Physiological Role of PP-Fold Peptide Receptor Subtypes. Exp Biol Med (Maywood) 2003;228:217-44. [DOI: 10.1177/153537020322800301] [Cited by in Crossref: 203] [Cited by in F6Publishing: 163] [Article Influence: 33.8] [Reference Citation Analysis]
55 Parker MS, Sah R, Parker SL. Surface masking shapes the traffic of the neuropeptide Y Y2 receptor. Peptides 2012;37:40-8. [PMID: 22732667 DOI: 10.1016/j.peptides.2012.06.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
56 Gehlert DR, Shaw JL. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function. Peptides 2007;28:241-9. [PMID: 17208335 DOI: 10.1016/j.peptides.2006.08.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
57 Holliday ND, Michel MC, Cox HM. NPY Receptor Subtypes and Their Signal Transduction. In: Michel MC, editor. Neuropeptide Y and Related Peptides. Berlin: Springer Berlin Heidelberg; 2004. pp. 45-73. [DOI: 10.1007/978-3-642-18764-3_3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
58 Tough IR, Holliday ND, Cox HM. Y(4) receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa. J Pharmacol Exp Ther 2006;319:20-30. [PMID: 16807358 DOI: 10.1124/jpet.106.106500] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
59 Parker SL, Balasubramaniam A. Neuropeptide Y Y2 receptor in health and disease. Br J Pharmacol 2008;153:420-31. [PMID: 17828288 DOI: 10.1038/sj.bjp.0707445] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
60 Parker SL, Parker MS, Wong YY, Sah R, Balasubramaniam A, Sallee F. Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor. Eur J Pharmacol 2008;594:26-31. [PMID: 18700141 DOI: 10.1016/j.ejphar.2008.07.038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
61 Li J, Tian Y, Wu A. Neuropeptide Y receptors: a promising target for cancer imaging and therapy. Regen Biomater 2015;2:215-9. [PMID: 26816643 DOI: 10.1093/rb/rbv013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]